Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis
Clinical trial NCT02309515 · TERMINATED
Trial details
- NCT number
- NCT02309515
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-11
- Primary completion
- 2017-04-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.